(6) Some recent studies are using a fusion engineering approach where MDA-7/IL-24 is fused with cell penetrating peptides (CPPs) or tumor homing peptides [157,158] to target it to neighboring tumor sites to enhance its therapeutic efficiency. This evidence concerns the gene IL24 and neoplasm.